Treatment of Leukoplakia of Vagina with Squamous Cell Hyperplasia of the Vulva

Clinical Scenario

This protocol addresses leukoplakia of the vagina presenting in the context of squamous cell hyperplasia of the vulva (SCHV) — one of two non-neoplastic epithelial disorders of the vulva, alongside vulvar lichen sclerosus, that are collectively referred to as vulvar leukoplakia.

Condition

Squamous cell hyperplasia of the vulva (SCHV) represents a distinct non-neoplastic epithelial disorder. Recognising this specific diagnosis is important, as it informs the range of therapeutic strategies appropriate for this patient population.

Treatment Approach

Management of leukoplakia of the vagina in SCHV includes destructive and surgical modalities designed to address the affected tissue — the full structured regimen specifies which options apply and under what conditions.

Full protocol with complete options available below →

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.5114/pm.2020.99570

Two non-neoplastic epithelial disorders of the vulva – vulvar LS (VLS) and squamous cell hyperplasia of the vulva (SCHV) – are generally referred to as vulvar leukoplakia.

Vaporization, ultrasonic surgical aspiration, loop excision, simple lesion excision, and cryotherapy are some further therapeutic options to broaden the spectrum of SCHV treatment options.

View source ↗